Novel assay technologies for the discovery of G protein-coupled receptor drugs

Neuromethods

Volumn 60, Issue , 2011, Pages 231-253

  Alvarez Curto, Elisa ^b   Ward, Richard J ^b   Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NONE

Author keywords

Cell based assay; Fluorescent ligand; High throughput screening; Homogeneous; Label free assay; Orphan GPCR; Protein complementation

Indexed keywords

BETA ARRESTIN; G PROTEIN COUPLED RECEPTOR;

ANALYTIC METHOD; CHEMOLUMINESCENCE; DRUG DESIGN; DRUG DEVELOPMENT; FLUORESCENCE ANALYSIS; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIGAND BINDING; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 79960956093     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-61779-179-6_12     Document Type: Review

References (65)

1. Mayr LM, Bojanic D (2009) Novel trends in high-throughput screening. Curr Opin Pharmacol 9:580-588.
2. Peters MF, Knappenberger KS, Wilkins D et al (2007) Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs. J Biomol Screen 12:312-319. (Pubitemid 46514669)
3. Peters MF, Scott CW (2009) Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity. J Biomol Screen 14:246-255.
4. Antony J, Kellershohn K, Mohr-Andra M et al (2009) Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity. FASEB J 23:442-450.
5. Kebig A, Kostenis E, Mohr K et al (2009) An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators. J Recept Signal Transduct Res 29:140-145.
6. Lee T, Schwandner R, Swaminath G et al (2008) Identifcation and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol 74:1599-1609.
7. Shemesh R, Toporik A, Levine Z et al (2008) Discovery and validation of novel peptide agonists for G-protein-coupled receptors. J Biol Chem 283:34643-34649.
8. McLoughlin D, Bertelli F, Williams C (2007) The A, B, Cs of G-protein-coupled receptor pharmacology in assay development for HTS. Expert Opin Drug Discov 2:603-619. (Pubitemid 47071655)
9. Gossman DG, Zhao HB (2008) Hemichannel-mediated inositol 1,4,5-trisphosphate (IP3) release in the cochlea: a novel mechanism of IP3 intercellular signalling. Cell Commun Adhes 15:305-315.
10. Trinquet E, Fink M, Bazin H et al (2006) D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. Anal Biochem 358:126-135. (Pubitemid 44511899)
11. Ayoub MA, Maurel D, Binet V et al (2007) Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells. Mol Pharmacol 71:1329-1340. (Pubitemid 46658686)
12. Violin JD, Lefkowitz RJ (2007) Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28:416-422.
13. DeWire SM, Ahn S, Lefkowitz RJ et al (2007) Beta-arrestins and cell signalling. Ann Rev Physiol 69:483-510.
14. Chen W, Hu LA, Semenov MV et al (2001) Beta-arrestin 1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins. Proc Natl Acad Sci USA 98:14889-14894. (Pubitemid 34013940)
15. Schulte G, Schambony A, Bryja V (2010) Beta-arrestins-scaffolds and signalling elements essential for WNT/Frizzled signalling pathways? Br J Pharmacol 159:1051-1058.
16. Lin F T, Daaka Y, Lefkowitz RJ (1998) Beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulinlike growth factor I receptor. J Biol Chem 273:31640-31643. (Pubitemid 29177090)
17. Doucette C, Vedvik K, Koepnick E et al (2009) Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays. J Biomol Screen 14:381-394.
18. Patel A, Murray J, McElwee-Whitmer S et al (2009) A combination of ultrahigh throughput PathHunter and cytokine secretion assays to identify glucocorticoid receptor agonists. Anal Biochem 385:286-292.
19. Yin H, Chu A, Li W et al (2009) Lipid G protein-coupled receptor ligand identifcation using beta-arrestin PathHunter assay. J Biol Chem 284:12328-12338.
20. van der Lee MM, Blomenrohr M, van der Doelen AA et al (2009) Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1. J Biomol Screen 14:811-823.
21. McGuinness D, Malikzay A, Visconti R et al (2009) Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay. J Biomol Screen 14:49-58.
22. Kocan M, Pfeger KD (2009) Detection of GPCR/beta-arrestin interactions in live cells using bioluminescence resonance energy transfer technology. Methods Mol Biol 552: 305-317.
23. Pfeger KD, Seeber RM, Eidne KA (2006) Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat Protoc 1:337-345.
24. Masri B, Salahpour A, Didriksen M et al (2008) Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsy-chotics. Proc Natl Acad Sci USA 105: 13656-13661.
25. Klewe IV, Nielsen SM, Tarpo L et al (2008) Recruitment of beta-arrestin 2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signalling. Neuropharmacology 54:1215-1222.
26. Garippa RJ, Hoffman AF, Gradl G et al (2006) High-throughput confocal microscopy for beta-arrestin-green fuorescent protein trans-location G protein-coupled receptor assays using the Evotec Opera. Methods Enzymol 414:99-120. (Pubitemid 44716219)
27. Barak LS, Ferguson SS, Zhang J et al (1997) A beta-arrestin/green fuorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem 272:27497-27500. (Pubitemid 27473532)
28. Kapur A, Zhao P, Sharir H et al (2009) Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 284: 29817-29827.
29. Smith GP. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-1317. (Pubitemid 15000355)
30. Szardenings M, Tornroth S, Mutulis F et al (1997) Phage display selection on whole cells yields a peptide specifc for melanocortin receptor 1. J Biol Chem 272:27943-27948. (Pubitemid 27473599)
31. Houimel M, Loetscher P, Baggiolini M et al (2001) Functional inhibition of CCR3-dependent responses by peptides derived from phage libraries. Eur J Immunol 31:3535-3545. (Pubitemid 34030966)
32. Hessling J, Lohse MJ, and Klotz KN (2003) Peptide G protein agonists from a phage display library. Biochem Pharmacol 65:961-967. (Pubitemid 36293678)
33. Bikkavilli RK, Tsang SY, Tang WM et al (2006) Identifcation and characterization of surrogate peptide ligand for orphan G protein-coupled receptor mas using phage-displayed peptide library. Biochem Pharmacol 71:319-337. (Pubitemid 41817292)
34. Congreve M, Murray CW, Blundell TL (2005) Structural biology and drug discovery. Drug Discov Today 10:895-907.
35. Palczewski K, Kumasaka T, Hori T et al (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289:739-745. (Pubitemid 30650186)
36. Cherezov V, Rosenbaum DM, Hanson MA et al (2007) High-resolution crystal structure of an engineered human beta 2-adrenergic G protein-coupled receptor. Science 318: 1258-1265. (Pubitemid 350172884)
37. Rasmussen SG, Choi HJ, Rosenbaum DM et al (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450:383-387. (Pubitemid 350126755)
38. Jaakola VP, Griffth MT, Hanson MA et al (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322:1211-1217.
39. Congreve M, Marshall F (2010) The impact of GPCR structures on pharmacology and structure-based drug design. Br J Pharmacol 159:986-996.
40. Bowie JU (2001) Stabilizing membrane proteins. Curr Opin Struct Biol 11:397-402. (Pubitemid 32728488)
41. Zhou Y, Bowie JU (2000) Building a thermostable membrane protein. J Biol Chem 275:6975-6979. (Pubitemid 30146241)
42. Lau FW, Nauli S, Zhou Y et al (1999) Changing single side-chains can greatly enhance the resistance of a membrane protein to irreversible inactivation. J Mol Biol 290:559-564. (Pubitemid 29324839)
43. Serrano-Vega MJ, Magnani F, Shibata Y et al (2008) Conformational thermostabilization of the beta 1-adrenergic receptor in a detergent-resistant form. Proc Natl Acad Sci USA 105:877-882. (Pubitemid 351282049)
44. Warne T, Serrano-Vega MJ, Baker JG et al (2008) Structure of a beta 1-adrenergic G-protein-coupled receptor. Nature 454: 486-491.
45. Bond RA, Ijzerman AP (2006) Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci 27:92-96. (Pubitemid 43184030)
46. Gupta A, Heimann AS, Gomes I et al (2008) Antibodies against G-protein coupled receptors: novel uses in screening and drug development. Comb Chem High Throughput Screen 11:463-467. (Pubitemid 351969362)
47. Peter JC, Wallukat G, Tugler J et al (2004) Modulation of the M2 muscarinic acetylcho-line receptor activity with monoclonal anti-M2 receptor antibody fragments. J Biol Chem 279:55697-55706. (Pubitemid 40066575)
48. Vidi PA, Watts VJ. (2009) Fluorescent and bioluminescent protein-fragment complementation assays in the study of G protein-coupled receptor oligomerization and signalling. Mol Pharmacol 75:733-739.
49. Hu CD, Chinenov Y, Kerppola TK (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimo-lecular fuorescence complementation. Mol Cell 9:789-798. (Pubitemid 34454889)
50. MacDonald ML, Lamerdin J, Owens S et al (2006) Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2:329-337. (Pubitemid 43787215)
51. Middleton RJ, Kellam B (2005) Fluorophore-tagged GPCR ligands. Curr Opin Chem Biol 9:517-525. (Pubitemid 41338206)
52. Cordeaux Y, Briddon SJ, Alexander SP et al (2008) Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells. FASEB J 22:850-860. (Pubitemid 351350620)
53. Chini B, Parenti M (2004) G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32:325-338. (Pubitemid 38584639)
54. Ostrom RS, Insel PA (2004) The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143:235-245. (Pubitemid 39315143)
55. Elson EL (2004) Quick tour of fuorescence correlation spectroscopy from its inception. J Biomed Opt 9:857-864. (Pubitemid 41268667)
56. Briddon SJ, Gandia J, Amaral OB et al (2008) Plasma membrane diffusion of G protein-coupled receptor oligomers. Biochim Biophys Acta 1783:2262-2268.
57. Briddon SJ, Middleton RJ, Cordeaux Y et al (2004) Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells. Proc Natl Acad Sci USA 101:4673-4678. (Pubitemid 38437469)
58. Briddon SJ, Hill SJ (2007) Pharmacology under the microscope: the use of fuorescence correlation spectroscopy to determine the properties of ligand-receptor complexes. Trends Pharmacol Sci 28:637-645. (Pubitemid 350166574)
59. Hegener O, Prenner L, Runkel F et al (2004) Dynamics of beta 2-adrenergic receptor-ligand complexes on living cells. Biochemistry 43:6190-6199. (Pubitemid 38669487)
60. Haasen D, Schnapp A, Valler MJ et al (2006) G protein-coupled receptor internalization assays in the high-content screening format. Methods Enzymol 414:121-139. (Pubitemid 44716220)
61. Beaudet A, Nouel D, Stroh T et al (1998) Fluorescent ligands for studying neuropeptide receptors by confocal microscopy. Braz J Med Biol Res 31:1479-1489. (Pubitemid 128528301)
62. O'Dowd BF, Alijaniaram M, Ji X et al (2007) Using ligand-induced conformational change to screen for compounds targeting G-protein-coupled receptors. J Biomol Screen 12: 175-185. (Pubitemid 46364432)
63. Gautier A, Juillerat A, Heinis C et al (2008) An engineered protein tag for multiprotein labeling in living cells. Chem Biol 15:128-136. (Pubitemid 351253620)
64. Maurel D, Comps-Agrar L, Brock C et al (2008) Cell-surface protein-protein interaction analysis with time-resolved FRET and SNAP-tag technologies: application to GPCR oligomerization. Nat Methods 5:561-567. (Pubitemid 351761765)
65. Kofuku Y, Yoshiura C, Ueda T et al (2009) Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4. J Biol Chem 284:35240-35250.